company background image
603392 logo

Beijing Wantai Biological Pharmacy Enterprise SHSE:603392 Stock Report

Last Price

CN¥68.12

Market Cap

CN¥86.4b

7D

6.7%

1Y

1.1%

Updated

31 May, 2024

Data

Company Financials +

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

SHSE:603392 Stock Report

Market Cap: CN¥86.4b

603392 Stock Overview

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

603392 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth6/6
Past Performance1/6
Financial Health5/6
Dividends1/6

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beijing Wantai Biological Pharmacy Enterprise
Historical stock prices
Current Share PriceCN¥68.12
52 Week HighCN¥88.00
52 Week LowCN¥40.14
Beta2.32
1 Month Change-0.23%
3 Month Change-9.19%
1 Year Change1.12%
3 Year Change-41.33%
5 Year Changen/a
Change since IPO1,436.49%

Recent News & Updates

Some Investors May Be Willing To Look Past Beijing Wantai Biological Pharmacy Enterprise's (SHSE:603392) Soft Earnings

Apr 04
Some Investors May Be Willing To Look Past Beijing Wantai Biological Pharmacy Enterprise's (SHSE:603392) Soft Earnings

Things Look Grim For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) After Today's Downgrade

Apr 02
Things Look Grim For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) After Today's Downgrade

Recent updates

Some Investors May Be Willing To Look Past Beijing Wantai Biological Pharmacy Enterprise's (SHSE:603392) Soft Earnings

Apr 04
Some Investors May Be Willing To Look Past Beijing Wantai Biological Pharmacy Enterprise's (SHSE:603392) Soft Earnings

Things Look Grim For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) After Today's Downgrade

Apr 02
Things Look Grim For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) After Today's Downgrade

Earnings Tell The Story For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) As Its Stock Soars 27%

Feb 28
Earnings Tell The Story For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) As Its Stock Soars 27%

Shareholder Returns

603392CN BiotechsCN Market
7D6.7%-1.9%-1.5%
1Y1.1%-20.1%-11.8%

Return vs Industry: 603392 exceeded the CN Biotechs industry which returned -20.1% over the past year.

Return vs Market: 603392 exceeded the CN Market which returned -11.8% over the past year.

Price Volatility

Is 603392's price volatile compared to industry and market?
603392 volatility
603392 Average Weekly Movement7.0%
Biotechs Industry Average Movement6.1%
Market Average Movement6.6%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 603392 has not had significant price volatility in the past 3 months.

Volatility Over Time: 603392's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19913,843Zhiming Jiangwww.ystwt.com

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines.

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Fundamentals Summary

How do Beijing Wantai Biological Pharmacy Enterprise's earnings and revenue compare to its market cap?
603392 fundamental statistics
Market capCN¥86.39b
Earnings (TTM)CN¥128.47m
Revenue (TTM)CN¥3.38b

672.5x

P/E Ratio

25.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603392 income statement (TTM)
RevenueCN¥3.38b
Cost of RevenueCN¥962.90m
Gross ProfitCN¥2.41b
Other ExpensesCN¥2.29b
EarningsCN¥128.47m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.10
Gross Margin71.48%
Net Profit Margin3.80%
Debt/Equity Ratio2.5%

How did 603392 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

314%

Payout Ratio

Does 603392 pay a reliable dividends?

See 603392 dividend history and benchmarks
When do you need to buy 603392 by to receive an upcoming dividend?
Beijing Wantai Biological Pharmacy Enterprise dividend dates
Ex Dividend DateJun 03 2024
Dividend Pay DateJun 03 2024
Days until Ex dividend2 days
Days until Dividend pay date2 days

Does 603392 pay a reliable dividends?

See 603392 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.